CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $27,727,000 | +16.4% | 245,151 | +3.1% | 0.01% | +10.0% |
Q1 2017 | $23,819,000 | -2.1% | 237,885 | +5.1% | 0.01% | -9.1% |
Q4 2016 | $24,340,000 | -9.6% | 226,378 | 0.0% | 0.01% | -15.4% |
Q3 2016 | $26,915,000 | +22.6% | 226,378 | +9.7% | 0.01% | +30.0% |
Q2 2016 | $21,947,000 | +15.5% | 206,428 | +24.3% | 0.01% | +11.1% |
Q1 2016 | $19,004,000 | -2.0% | 166,007 | +22.0% | 0.01% | -10.0% |
Q4 2015 | $19,390,000 | +417.8% | 136,107 | +226.4% | 0.01% | +400.0% |
Q3 2015 | $3,745,000 | – | 41,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |